Lista de obras - Giovanni Caocci - Dominio Público Uruguay

A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation

artículo científico publicado en 2020

A mathematical model for the evaluation of amplitude of hemoglobin fluctuations in elderly anemic patients affected by myelodysplastic syndromes: correlation with quality of life and fatigue.

artículo científico publicado en 2006

A simulated case of chronic myeloid leukemia: the growing risk of Munchausen's syndrome by internet

artículo científico publicado en 2008

Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma

artículo científico publicado en 2013

Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib

artículo científico publicado en 2012

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

artículo científico publicado en 2015

Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.

artículo científico publicado en 2012

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart

scientific article published on 17 April 2019

Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis.

artículo científico publicado en 2018

Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients.

artículo científico publicado en 2010

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

scientific article published on 14 May 2020

Daunorubicin, cytarabine, and cladribine regimen plus radiotherapy and donor lymphocyte infusion for extramedullary relapse of acute myeloid leukemia after hematopoietic stem cell transplantation

artículo científico publicado en 2013

Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues

artículo científico publicado en 2006

Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial).

artículo científico publicado en 2014

Different perception of surgical risks between physicians and patients undergoing laparoscopic cholecystectomy

artículo científico publicado en 2009

Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript.

artículo científico publicado en 2013

Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis

scientific article published on 14 June 2019

Ethical concerns surrounding the conception of an HLA compatible child for medical purposes

artículo científico publicado en 2012

Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

artículo científico publicado en 2011

Familial occurrence of chronic myeloid leukemia

artículo científico publicado en 2009

Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib

scientific article published on 29 June 2020

Guillain-Barré syndrome after human herpesvirus-6 reactivation in unrelated hematopoietic stem cell transplantation

artículo científico publicado en 2013

Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia

artículo científico publicado en 2008

Health related quality of life in Middle Eastern children with beta-thalassemia

artículo científico publicado en 2012

Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes

artículo científico publicado en 2009

Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned?

artículo científico

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

scientific article published on 02 September 2019

Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients

artículo científico publicado en 2013

Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatment.

artículo científico publicado en 2018

Immunological deregulation in classic hodgkin lymphoma.

artículo científico publicado en 2014

Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice

scientific article published on 01 May 2019

Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm

artículo científico publicado en 2011

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.

artículo científico publicado en 2013

Isolated jejunal perforation after blunt trauma. Report of three cases

scientific article published on 01 April 2010

Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients

artículo científico publicado en 2015

Leucocyte classification for leukaemia detection using image processing techniques

artículo científico publicado en 2014

Long-term efficacy and tolerance of rituximab for post-transfusional alloimmune haemolytic anaemia in a thalassaemia patient

artículo científico publicado en 2007

Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia

artículo científico publicado en 2013

Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment

artículo científico publicado en 2017

Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

artículo científico publicado en 2020

Low-Dose Ponatinib Is A Good Option In Chronic Myeloid Leukemia Patients Intolerant To Previous Tkis

scientific article published on 17 June 2020

Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

scientific article published on 20 April 2020

Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis.

artículo científico publicado en 2015

Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias

artículo científico publicado en 2008

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

scientific article published on 28 February 2019

Occurrence of immune thrombocytopenic purpura in a patient with essential thrombocythemia: How the immune system can overcome a neoplastic clone

artículo científico publicado en 2020

Overcoming scientific barriers and human prudence

scientific article published on 01 December 2006

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

artículo científico publicado en 2017

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes.

artículo científico publicado en 2014

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

artículo científico publicado en 2014

Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

scientific article published on 09 January 2012

Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation

artículo científico publicado en 2010

Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis.

artículo científico publicado en 2013

Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

artículo científico publicado en 2014

Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia.

artículo científico publicado en 2011

Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission.

artículo científico publicado en 2018

Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190(BCR-ABL) oncoprotein and JAK2V617F mutation

artículo científico publicado en 2009

Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes.

artículo científico publicado en 2013

Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

artículo científico publicado en 2021

Ruxolitinib therapy and telomere length in myelofibrosis

artículo científico publicado en 2016

Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report.

artículo científico publicado en 2014

Second primary malignancy in myelofibrosis patients treated with ruxolitinib

artículo científico publicado en 2020

Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients

artículo científico publicado en 2007

Successful and safe stem cell mobilization using plerixafor in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia

artículo científico publicado en 2013

Superior sagittal sinus thrombosis after lumbar puncture in a patient with T-cell lymphoblastic lymphoma: role of the prothrombin G20210A mutation and 4G/4G genotype

artículo científico publicado en 2005

Systemic Mastocytosis with Associated Primary Myelofibrosis

scientific article published on 28 October 2019

Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia

scientific article published on 06 December 2019

T cell tyrosine phosphorylation response to transient redox stress.

artículo científico publicado en 2015

Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients

artículo científico publicado en 2016

The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia

scientific article published on 01 October 2007

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia

scientific article published on 22 February 2010

Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major

artículo científico publicado en 2008

Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis

artículo científico publicado en 2006

Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group

scientific article published on 01 January 2005

Unrelated bone marrow transplantation in thalassemia. The experience of the Italian Bone Marrow Transplant Group (GITMO).

artículo científico publicado en 2002

Unrelated donor stem cell transplantation in adult patients with thalassemia

artículo científico publicado en 2005

Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group

artículo científico publicado en 2012

Lista de obras de Giovanni Caocci

A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation

A mathematical model for the evaluation of amplitude of hemoglobin fluctuations in elderly anemic patients affected by myelodysplastic syndromes: correlation with quality of life and fatigue.

A simulated case of chronic myeloid leukemia: the growing risk of Munchausen's syndrome by internet

Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma

Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart

Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis.

Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients.

Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

Daunorubicin, cytarabine, and cladribine regimen plus radiotherapy and donor lymphocyte infusion for extramedullary relapse of acute myeloid leukemia after hematopoietic stem cell transplantation

Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues

Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial).

Different perception of surgical risks between physicians and patients undergoing laparoscopic cholecystectomy

Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript.

Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis

Ethical concerns surrounding the conception of an HLA compatible child for medical purposes

Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

Familial occurrence of chronic myeloid leukemia

Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib

Guillain-Barré syndrome after human herpesvirus-6 reactivation in unrelated hematopoietic stem cell transplantation

Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia

Health related quality of life in Middle Eastern children with beta-thalassemia

Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes

Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned?

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy

Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients

Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatment.

Immunological deregulation in classic hodgkin lymphoma.

Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice

Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.

Isolated jejunal perforation after blunt trauma. Report of three cases

Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients

Leucocyte classification for leukaemia detection using image processing techniques

Long-term efficacy and tolerance of rituximab for post-transfusional alloimmune haemolytic anaemia in a thalassaemia patient

Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia

Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment

Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

Low-Dose Ponatinib Is A Good Option In Chronic Myeloid Leukemia Patients Intolerant To Previous Tkis

Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis.

Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

Occurrence of immune thrombocytopenic purpura in a patient with essential thrombocythemia: How the immune system can overcome a neoplastic clone

Overcoming scientific barriers and human prudence

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes.

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation

Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis.

Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia.

Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission.

Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190(BCR-ABL) oncoprotein and JAK2V617F mutation

Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes.

Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

Ruxolitinib therapy and telomere length in myelofibrosis

Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report.

Second primary malignancy in myelofibrosis patients treated with ruxolitinib

Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients

Successful and safe stem cell mobilization using plerixafor in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia

Superior sagittal sinus thrombosis after lumbar puncture in a patient with T-cell lymphoblastic lymphoma: role of the prothrombin G20210A mutation and 4G/4G genotype

Systemic Mastocytosis with Associated Primary Myelofibrosis

Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia

T cell tyrosine phosphorylation response to transient redox stress.

Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients

The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia

Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major

Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis

Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group

Unrelated bone marrow transplantation in thalassemia. The experience of the Italian Bone Marrow Transplant Group (GITMO).

Unrelated donor stem cell transplantation in adult patients with thalassemia

Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group